HCA Reports Fourth Quarter 2018 Results and Provides 2019 Guidance

Go back to HCA Reports Fourth Quarter 2018 Results and Provides 2019 Guidance

HCA Holdings (HCA) PT Raised to $150 at Oppenheimer

January 30, 2019 8:42 AM EST

Oppenheimer analyst Michael Wiederhorn raised the price target on HCA Holdings (NYSE: HCA) to $150.00 (from $142.00) while maintaining a Outperform rating.

... More

HCA Holdings (HCA) PT Raised to $153 at Mizuho Securities Following 4Q

January 30, 2019 7:19 AM EST

Mizuho Securities analyst Ann Hynes raised the price target on HCA Holdings (NYSE: HCA) to $153.00 (from $150.00) while maintaining a Buy rating following the company's 4Q earnings report. Revenue beat consensus, driven by
strong same-facility admission and revenue/admission growth of +1.9% and +4.4%, respectively. Both... More

HCA Holdings (HCA) PT Raised to $160 at Deutsche Bank

January 29, 2019 5:27 PM EST

Deutsche Bank analyst Pito Chickering raised the price target on HCA Holdings (NYSE: HCA) to $160.00 (from $140.00) while maintaining a Buy rating.

... More

HCA Holdings (HCA) Raises Quarterly Dividend 14.3% to $0.40; Approves $2B Buyback

January 29, 2019 8:33 AM EST

HCA Holdings (NYSE: HCA) declared a quarterly dividend of $0.40 per share, or $1.6 annualized. This is a 14.3% increase from the prior dividend of $0.35.

The dividend will be payable on March 29, 2019, to stockholders of record on March 1, 2019, with an ex-dividend date of February 28,... More

HCA Holdings (HCA) Tops Q4 EPS by 43c, Offers FY Guidance

January 29, 2019 8:32 AM EST

HCA Holdings (NYSE: HCA) reported Q4 EPS of $3.01, $0.43 better than the analyst estimate of $2.58. Revenue for the quarter came in at $12.27 billion versus the consensus estimate of $12.1 billion.

GUIDANCE:

HCA Holdings sees FY2019 EPS of $9.60-$10.20, versus the consensus of... More